Dr. Reddy’s Laboratories Limited (NYSE:RDY) is one of the Best Indian Stocks to Buy According to Hedge Funds. On March 21, ...

After its third quarter results, the management of Dr. Reddy's Laboratories had said that they expect to hear on the ...

Citi flags recent 9 per cent rally in Dr. Reddy's Laboratories as overstated; says potential Semaglutide opportunity may not ...

Dr. Reddy's Laboratories jumps 7% as NIFTY Pharma rises 2.33%. Explore key reasons behind the rally, including rupee weakness, export gains, and defensive sector rotation.

Dr Reddy’s Laboratories has received the Drug Identification Numbers (DINs) for Semaglutide Injection from Health Canada as ...

Detailed price information for Dr. Reddy's Laboratories Ltd ADR (RDY-N) from The Globe and Mail including charting and trades.

Glenmark Pharma, Cipla, Wockhardt, Mankind Pharma, Lupin, Zydus Life, Laurus, Ipca Labs, Divis Labs, Strides Pharma and ...

Stay updated with the Dr Reddys Stock Liveblog, your one-stop destination for real-time information and analysis of a leading ...

TCS will kick start the Q4 earnings season later in the day. Industrial Production data for February and March inflation ...

Ongoing price erosion in key products remains a lingering concern for Dr. Reddy's and therefore, Goldman Sachs has cut its ...

Dr. Reddy's Laboratories Ltd. closed 11.41% below its 52-week high of 1,377.95 rupees, which the company achieved on June 12th.

Dr. Reddy’s Laboratories Limited (NYSE:RDY) is one of the Best Indian Stocks to Buy for Next 5 Years. Dr. Reddy’s Laboratories Limited (NYSE:RDY) and Alvotech announced that they have entered into a ...